Fresenius Medical Care AG FMS
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.95% | 5.05% | 8.88% | 9.13% | 6.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.95% | 5.05% | 8.88% | 9.13% | 6.00% |
| Cost of Revenue | 1.71% | 3.22% | 5.39% | 7.18% | 4.78% |
| Gross Profit | 10.55% | 10.76% | 19.34% | 15.26% | 9.77% |
| SG&A Expenses | -4.76% | 10.92% | 2.06% | -0.79% | 8.25% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 208.31% | 129.60% | -5.87% | 93.78% | 55.50% |
| Total Operating Expenses | 1.07% | 4.68% | 4.57% | 6.80% | 5.55% |
| Operating Income | 36.06% | 9.38% | 58.25% | 34.77% | 11.36% |
| Income Before Tax | 11.97% | -7.95% | 210.01% | 12.50% | 8.89% |
| Income Tax Expenses | 17.63% | -22.13% | 90.57% | -31.35% | -16.66% |
| Earnings from Continuing Operations | 10.34% | -3.39% | 271.69% | 31.86% | 19.41% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -62.99% | -36.81% | -59.79% | -9.64% | 7.17% |
| Net Income | -0.66% | -13.59% | 433.92% | 37.18% | 27.00% |
| EBIT | 36.06% | 9.38% | 58.25% | 34.77% | 11.36% |
| EBITDA | 20.16% | 6.75% | 39.58% | 19.16% | 6.19% |
| EPS Basic | 8.60% | -7.89% | 448.02% | 37.80% | 26.99% |
| Normalized Basic EPS | 15.40% | 9.51% | 66.24% | 55.29% | 25.21% |
| EPS Diluted | 8.13% | -7.89% | 467.89% | 37.68% | 26.99% |
| Normalized Diluted EPS | 15.40% | 9.51% | 66.24% | 55.29% | 25.21% |
| Average Basic Shares Outstanding | -8.51% | -6.19% | -2.56% | -0.45% | 0.00% |
| Average Diluted Shares Outstanding | -8.51% | -6.19% | -2.56% | -0.45% | 0.00% |
| Dividend Per Share | -- | -- | 13.00% | -- | -- |
| Payout Ratio | -0.02% | -- | -- | -- | 0.00% |